Skip to main content
. 2020 Oct 14;23(11):1426–1443. doi: 10.1089/jpm.2020.0220

Table 1.

Characteristics of the Trials on General/Specialist Palliative Care (Clinical Questions 1 and 2) and of Trial Participants

Study
 
 
 
 
MS patients (%)
Carers (%)
Intervention Country (name) No. of centres Length (weeks) Risk of bias (low/high) No. Age3 Women EDSSb No. Agea Women Relation
Specialist PC home-based UK - 1 12 Selection (low)c Selection (low)d Performance (high) Detection (high) Attrition (low) Reporting (low) Other (low) 52 53.0 (33–75) 36 (69) 7.5 (5.5–9.5) 43 - - Partner/spouse 29 (67) Son/daughter 7 (16) Parent 4 (10) Other relative 3 ( 7) Paid carer 0(0)
Specialist PC home-based Italy (NE-PAL) 1 16 Selection (low)c Selection (low)d Performance (high) Detection (high) Attrition (low) Reporting (low) Other (low) 18 54.2 (40–71) 10 (56) 8.5 7.0–9.5) 18 - 14 (78) Partner/spouse 11 (61) Son/daughter 1 ( 5) Parent 2 (10) Other relative 1 ( 5) Paid carer 3 (17)
General PC home-based Italy (PeNSAMI) 3 24 Selection (low)c Selection (low)d Performance (high) Detection (low) Attrition (low) Reporting (low) Other (low) 76 59.2 (41–80) 43 (57) 8.5 (8.0–9.5) 76 60.3 (23–84) 47 (62) Partner/spouse 40 (53) Son/daughter 8(11) Parent 12 (16) Other relative 13 (17) Paid carer 3(4)

EDSS, Expanded Disability Status Scale; MS, multiple sclerosis; PC, palliative care. aMean (range). bMedian (range). cRandom sequence generation. dAllocation concealment.